MEAGAN SMOYER: Open Payments
NPI 1871072546 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 32 payments from 17 companies in 2025. Trend: 2023 $2,063 · 2024 $875 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 4 | $108 |
| Sumitomo Pharma America, Inc. | 5 | $93 |
| IMMUNITYBIO, INC. | 3 | $68 |
| Dendreon Pharmaceuticals LLC | 3 | $66 |
| BLUEWIND MEDICAL | 1 | $65 |
| Janssen Biotech, Inc. | 3 | $65 |
| Ferring Pharmaceuticals Inc. | 2 | $53 |
| Valencia Technologies Corporation | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Davol Inc. | 1 | $32 |
Products named: AVEED, ANKTIVA, GEMTESA, PROVENGE, ERLEADA, ADSTILADRIN, eCoin Device Kit, KEYTRUDA.
Industry payments across MA — which companies pay providers there.
